Acme Packet, a company that provides session border controllers that enable interactive communications such as VoIP, has actually raised its terms for its proposed IPO set for pricing tonight.
The new proposed range is $8.00 to $9.00, up from $6.50-$7.50, so it may have an implied market cap of some $550 million. Underwriters in the deal are Goldman Sachs, Credit Suisse, J.P.Morgan and ThinkEquity.
The company has not specified plans for the money other than general corporate purposes such as acquisitions, capital expenditures and investments. Acme was founded in 2000 and it developed the Net-Net family of SBCs and started shipping in the second half of 2002. It lists Alcatel, Nokia, UTStarcom and Ercisson as its larger partners.
Acme began its sales cycle in 2003 and sales reached $36 million last year, essentially breaking even on earnings. In the first half of this year, revenue more than doubled over the prior year to $38 million and it posted an EPS equivalent on a pre-IPO basis of $0.21. Sprint and Time Warner Cable were the two largest customers, and 3 of its 200+ customers account for some 38% of revenues.
It doesn't look like any ties to VoIP have been tainted by Vonage (VG) as far as being an equipment supplier, maybe because Cbeyond (CBEY) has continued to perform so well since its IPO. The company managed to get here on only $45 million of total venture capital funding raised from Menlo Ventures, Canaan Partners, Advanced Technology Ventures, and Beachhead Capital.
Acme Packet has been assigned the ticker "APKT."
Jon Ogg is a partner in 24/7 Wall St., LLC; he does not own securities in the companies he covers.
Last updated: February 10, 2012: 04:53 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- January New Home Sales to be released at 10:00 ET
- February Consumer Sentiment to be released at 09:55 ET
- Churchill Downs acquires assets of Bluff Media
- Mario Monti: Far from certain there will be a Greek default, CNBC reports
- Energen to acquire proved Wolfberry properties
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?

